Elisabeth Fenwick, PhD, is chief scientific officer in OPEN Health’s HEOR & Market Access practice, based in Oxford in the United Kingdom. In this role, Liz is responsible for the scientific and technical vision for OPEN Health’s HEOR & Market Access practice and, together with the Scientific Office, for supporting the growth and dissemination of science ensuring that it is at the heart of all of OPEN Health’s HEOR & Market Access activities. Liz provides scientific and strategic support to health economics projects globally. She has extensive experience in economic evaluation and health economic modelling having worked in the field for over 20 years. Liz has undertaken projects in a wide range of clinical areas including cardiology, oncology, respiratory, infectious diseases, ophthalmology, orphan diseases, public health, and mental health. Liz has also contributed to methods in the field, in particular relating to decision analytic modelling and simulation methods, probabilistic decision analytic modelling, and value of information analysis. Liz was a member of the ISPOR-SMDM Joint Task Force on good research practices in modelling, a co-author on the Joint Task Force paper on uncertainty, and was co-chair of the ISPOR Task Force assessing emerging good practice in value of information analysis for research decisions.
Liz has a PhD and MSc in health economics as well as an MSc in operations research. Prior to her consultancy career, Liz spent over 15 years as an academic working at University of York, McMaster University, and University of Glasgow. Since leaving academia, Liz has continued to fulfil her passion for teaching through delivery of various short courses including courses held in conjunction with the ISPOR international and ISPOR Europe conferences covering advanced modelling methods, dynamic simulation models, conceptual modelling, value of information, and advanced survival modelling.
Liz is currently on the editorial board for Pharmacoeconomics and was previously the chair of the publications committee for SMDM. Liz has over 60 publications and 9500 citations (not all her own!).
ISPOR Vision Statement by Elisabeth Fenwick
The focus of my involvement with ISPOR, over the last 20 years, as both an academic and subsequently as a consultant, has been via the provision of short courses, workshops, issues panels, symposia, and through membership of Good Practice Task Forces in modelling and, more recently, value of information analysis for research decisions. I believe that it is crucial for ISPOR to be at the center of methods development and dissemination. This requires widening participation and enhancing capabilities, both through encouraging members to engage with existing opportunities such as short courses, reviewing, task forces, and by expanding membership and opportunities to embrace other disciplines and new talent. With my background and experience, I have worked with, and have connections across, the whole of ISPOR’s key stakeholders (researchers and academicians, assessors and regulators, payers and policymakers, healthcare providers, life science industry and patient engagement organizations).
If elected to represent ISPOR as a director, I would focus on delivering ISPOR’s Strategic Plan Update 2024, specifically through (1) Scientific and Research Excellence and (2) Education and Training.
- The Scientific and Research Excellence strategic pillar within the ISPOR Strategic Plan Update 2024, aligns closely with my role as Chief Scientific Officer at OPEN Health, HEOR & Market Access. Within this role, I am responsible for building on synergies between our various Centers of Excellence, across Modelling & Meta Analysis, Real-World Evidence, Patient-Centered Outcomes, Strategic Market Access, Patient Engagement, and Scientific Communications. The Scientific Office leads and supports innovation in, and dissemination of, methods across these Centers of Excellence.
- As an academic and subsequently in my consulting career, I have always valued the importance of training and skills development. I will contribute to the Education and Training strategic pillar through continued support for, and provision of, HEOR-focused education and training programs delivered in multiple formats. While at University of Glasgow, I developed HEOR courses for diverse audiences across the college of medical, veterinary, and life sciences and was responsible for setting up an MSc in health technology assessment. As a director, I will also continue to work with academics and non-academics to develop new programs for education in HEOR.
I have been a member of ISPOR for a number of years, regularly attending meetings in Europe and the United States, and I relish the opportunity to give something back to the Society and its members through involvement with the board.